Investigating how the APOE gene affects brain cell function in Alzheimer's disease.

The effects of APOE genotype in homeostatic microglial function in preclinical APOE mouse model

NIH-funded research Georgetown University · NIH-10922870

This study is looking at how a specific gene called APOE4 affects brain cells that help keep our brains healthy, using a special mouse model to see how these cells react to damage and inflammation, which could help us find new ways to treat Alzheimer's disease before it starts.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionGeorgetown University NIH-funded
Lab location1 site (Washington, United States)
Project IDNIH-10922870 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the APOE gene, particularly the APOE4 variant, in the function of microglial cells, which are crucial for maintaining brain health. Using a special mouse model that mimics human genetics, the researchers will explore how APOE4 influences microglial behavior, especially in response to damage and inflammation. The study aims to uncover the molecular mechanisms that lead to changes in microglial function before the onset of Alzheimer's disease, potentially revealing new targets for treatment.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a family history of Alzheimer's disease or those who carry the APOE4 allele.

Not a fit: Patients without any genetic predisposition to Alzheimer's disease or those who do not carry the APOE4 allele may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting the underlying mechanisms affected by the APOE4 genotype.

How similar studies have performed: Previous research has shown promising results in understanding the role of APOE in Alzheimer's disease, indicating that this approach has potential for significant findings.

Where this research is happening

Washington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.